ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12
August 05 2009 - 4:05PM
PR Newswire (US)
SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- ADVENTRX
Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that it will
hold a conference call on Wednesday, August 12, 2009 at 1:30 p.m.
Pacific (4:30 p.m. Eastern) to review financial results for the
second quarter and provide an update on its business. Individuals
interested in listening to the conference call may do so by dialing
(866) 305-6438 for domestic callers, or (706) 679-7161 for
international callers, or from the webcast on the investor
relations section of the Company's Web site at
http://www.adventrx.com/. A 48-hour telephone replay will be
available approximately one hour after the conclusion of the call
by dialing (800) 642-1687 for domestic callers, or (706) 645-9291
for international callers, and entering reservation code 23355569.
The webcast will be available on the Company's Web site for 14 days
following the completion of the call. About ADVENTRX ADVENTRX
Pharmaceuticals is a biopharmaceutical company whose product
candidates are designed to improve the safety of existing cancer
treatments. More information can be found on the Company's web site
at http://www.adventrx.com/. DATASOURCE: ADVENTRX Pharmaceuticals,
Inc. CONTACT: Brian Culley, Principal Executive Officer of ADVENTRX
Pharmaceuticals, +1-858-552-0866; or Investors, Don Markley of
Lippert/Heilshorn & Associates, Inc., +1-310-691-7100, , for
ADVENTRX Pharmaceuticals Web Site: http://www.adventrx.com/
Copyright